Live Breaking News & Updates on Extracorporeal|Page 5
Stay updated with breaking news from Extracorporeal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Project Spotlights Digital Engineering Leader's Decades-long History in Scalable, Rapid Software Innovation for Class III Medical Devices GlobalLogic Inc., a Hitachi Group Company and leader in ....
Halberd Corporation: Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects JACKSON CENTER, PA / ACCESSWIRE / June 1, 2021 / Halberd Corporation (OTC PINK:HALB) announced the filing of a U. S. joint provisional patent application titled, Antibody Conjugated Nanoparticle Assay And Treatment For SARS-CoV-2. The innovation is a result of Halberd s Sponsored Research conducted at Arizona State University (ASU). The provisional patent application covers technology developed to facilitate conjugation of metallic nanoparticles with antibodies against various bacteria and SARS-CoV-2, for elimination via radio waves. Additionally, the patent discloses the use of such a conjugated moiety as a means of detecting the presence and level of the SARS-CoV-2 viral load in a patient. ....
Baxter International Inc.: Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research Led by Baxter s renowned research and development team in Hechingen, Germany Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF). With the grant, Baxter will lead an initiative aiming to create a new technology platform enhancing the ability to target selective removal of pathogenic substances during certain extracorporeal (outside the body) blood purification (EBP) therapies. The grant provides €1.5 million in funding over three years to Baxter and its research partners through the BMBF s Biomaterials Platform: Mat2MedTech program. ....